Literature DB >> 15869815

Identification, expression, localization and serological characterization of a tryptophan-rich antigen from the human malaria parasite Plasmodium vivax.

Rashmi Jalah1, Ritu Sarin, Neetu Sud, Mohammad Tauqeer Alam, Neha Parikh, Taposh K Das, Yagya D Sharma.   

Abstract

Plasmodium vivax is most common but non-cultivable human malaria parasite which is poorly characterized at the molecular level. Here, we describe the identification and characterization of a P. vivax Tryptophan-Rich Antigen (PvTRAg) which contains unusually high (8.28%) tryptophan residues and is expressed by all blood stages of the parasite. The pvtrag gene comprises a 978bp open reading frame interrupted by two introns. The first intron is located in the 5'-untranslated region while the second one is positioned 174bp downstream to the ATG codon. The encoded approximately 40kDa protein contains a transmembrane domain near the N-terminus followed by a tryptophan-rich domain with significantly high surface probability and antigenic index. It is localized in the parasite cytoplasm as well as in the cytoplasm of the parasitized erythrocyte. The purified E. coli expressed recombinant PvTRAg protein showed a very high seropositivity rate for the presence of antibodies amongst the P. vivax patients, indicating that the antigen generates significant humoral immune response during the natural course of P. vivax infection. Analysis of various field isolates revealed that the tryptophan-rich domain is highly conserved except for three-point mutations. The PvTRAg could be a potential vaccine candidate since similar tryptophan-rich antigens of P. yoelii have shown protection against malaria in murine model.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15869815     DOI: 10.1016/j.molbiopara.2005.01.020

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  17 in total

1.  Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.

Authors:  Mohammad Tauqeer Alam; Hema Bora; Praveen K Bharti; Muheet A Saifi; Manoj K Das; Vas Dev; Ashwani Kumar; Neeru Singh; Aditya P Dash; Brahmananda Das; Yagya D Sharma
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

2.  A Sporozoite- and Liver Stage-expressed Tryptophan-rich Protein Plays an Auxiliary Role in Plasmodium Liver Stage Development and Is a Potential Vaccine Candidate.

Authors:  Dabbu Kumar Jaijyan; Himanshu Singh; Agam Prasad Singh
Journal:  J Biol Chem       Date:  2015-05-10       Impact factor: 5.157

3.  CD4+ T cell response correlates with naturally acquired antibodies against Plasmodium vivax tryptophan-rich antigens.

Authors:  Mohammad Zeeshan; Kriti Tyagi; Yagya D Sharma
Journal:  Infect Immun       Date:  2015-03-02       Impact factor: 3.441

4.  Immunoprofiling of the tryptophan-rich antigen family in Plasmodium vivax.

Authors:  Bo Wang; Feng Lu; Yang Cheng; Jun-Hu Chen; Hye-Yoon Jeon; Kwon-Soo Ha; Jun Cao; Myat Htut Nyunt; Jin-Hee Han; Seong-Kyun Lee; Myat Phone Kyaw; Jetsumon Sattabongkot; Eizo Takashima; Takafumi Tsuboi; Eun-Taek Han
Journal:  Infect Immun       Date:  2015-05-18       Impact factor: 3.441

5.  A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito.

Authors:  Scott J Westenberger; Colleen M McClean; Rana Chattopadhyay; Neekesh V Dharia; Jane M Carlton; John W Barnwell; William E Collins; Stephen L Hoffman; Yingyao Zhou; Joseph M Vinetz; Elizabeth A Winzeler
Journal:  PLoS Negl Trop Dis       Date:  2010-04-06

6.  The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites.

Authors:  Zbynek Bozdech; Sachel Mok; Guangan Hu; Mallika Imwong; Anchalee Jaidee; Bruce Russell; Hagai Ginsburg; Francois Nosten; Nicholas P J Day; Nicholas J White; Jane M Carlton; Peter R Preiser
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

7.  Expression, purification, and characterization of the immunological response to a 40-kilodalton Plasmodium vivax tryptophan-rich antigen.

Authors:  Asim A Siddiqui; Hema Bora; Neeru Singh; Aditya P Dash; Yagya D Sharma
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

8.  Comparative genomics of the neglected human malaria parasite Plasmodium vivax.

Authors:  Jane M Carlton; John H Adams; Joana C Silva; Shelby L Bidwell; Hernan Lorenzi; Elisabet Caler; Jonathan Crabtree; Samuel V Angiuoli; Emilio F Merino; Paolo Amedeo; Qin Cheng; Richard M R Coulson; Brendan S Crabb; Hernando A Del Portillo; Kobby Essien; Tamara V Feldblyum; Carmen Fernandez-Becerra; Paul R Gilson; Amy H Gueye; Xiang Guo; Simon Kang'a; Taco W A Kooij; Michael Korsinczky; Esmeralda V-S Meyer; Vish Nene; Ian Paulsen; Owen White; Stuart A Ralph; Qinghu Ren; Tobias J Sargeant; Steven L Salzberg; Christian J Stoeckert; Steven A Sullivan; Marcio M Yamamoto; Stephen L Hoffman; Jennifer R Wortman; Malcolm J Gardner; Mary R Galinski; John W Barnwell; Claire M Fraser-Liggett
Journal:  Nature       Date:  2008-10-09       Impact factor: 49.962

9.  Erythrocyte Binding Activity Displayed by a Selective Group of Plasmodium vivax Tryptophan Rich Antigens Is Inhibited by Patients' Antibodies.

Authors:  Rupesh Kumar Tyagi; Yagya Dutta Sharma
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

10.  Expression, Purification and Characterization of a Recombinant Plasmodium Vivax Thrombospondin Related Adhesive Protein (PvTRAP).

Authors:  Jamiu A Ogunbanwo; Prakash Rao Pendyala; Pawan Malhotra; Virander S Chauhan
Journal:  Int J Biomed Sci       Date:  2006-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.